Motor phenotypes associated with genetic neurodevelopmental disorders
Open Access
- 2 November 2024
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 11 (12) , 3238-3245
Abstract
Objective: There is a growing number of monogenic disorders implicated in neurodevelopmental disorders (NDDs), including autism spectrum disorder and intellectual disability. Motor impairment is frequently seen in these disorders, although not clearly defined. We aimed to characterize the motor phenotype of genetic NDDs.Methods: We analyzed data from Simons Searchlight, collecting information on patients with genetic NDDs. Data analyzed included Vineland Adaptive Behavior Scales Second Edition (Vineland‐II) motor standard scores, motor milestones and tone abnormalities.Results: In total, 959 patients with 57 genetic disorders were included. Disorders associated with Vineland‐II motor standard score GRIN2B‐related disorder (mean standard score = 53.5), HNRNPH2‐related disorder (mean standard score = 55.8) and SCN2A‐related disorder (mean standard score = 49.9). The only genetic condition with a mean age of sitting unsupported ≥18 months was GRIN1‐related disorder (mean age = 26.3 months). Genetic conditions with a mean age of walking independently ≥36 months included CTNNB1‐related disorder (mean age = 37.4 months) and HNRNPH2‐related disorder (mean age = 41.9 months). Tone abnormalities included hypotonia in 83% (577/696), hypertonia in 16% (112/696), a diagnosis of cerebral palsy (CP) in 10% (73/696) and a diagnosis specifically of spastic CP in 3% (23/696).Interpretation: Patients with genetic NDDs have a spectrum of motor impairment, which warrant further characterization.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (K23NS119666)
This publication has 28 references indexed in Scilit:
- Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Cerebral PalsyJAMA Neurology, 2022
- Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variantsGenetics in Medicine, 2022
- Underrepresentation of the term cerebral palsy in clinical genetics databasesAmerican Journal of Medical Genetics Part A, 2022
- Insufficient Evidence for “Autism-Specific” GenesThe American Journal of Human Genetics, 2020
- Clinical features associated with CTNNB1 de novo loss of function mutations in ten individualsEuropean Journal of Medical Genetics, 2017
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerThe Journal of Molecular Diagnostics, 2017
- Gait characteristics in individuals with intellectual disabilities: A literature reviewResearch in Developmental Disabilities, 2014
- Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidenceThe Lancet Neurology, 2013
- Simons Variation in Individuals Project (Simons VIP): A Genetics-First Approach to Studying Autism Spectrum and Related Neurodevelopmental DisordersNeuron, 2012
- Prevalence of motor impairment in autism spectrum disordersBrain and Development, 2007